Author:
Forsdyke, Donald R.
Document:
https://doi.org/10.1111/jep.12425
References:
1. Jones, D. S. & Podolsky, S. H. (2015) The history and fate of the gold standard. Lancet, 385, 1503–1504.
2. Appelboom, G., LoPresti, M., Reginster, J.-Y., Connolly, E. S. & Dumont, E. P. L. (2014) The quantified patient: a patient participatory culture. Current Medical Research & Opinion, 30, 2585–2587.
3. Zeliadt, N. (2014) Straight talking with Jamie Heywood. Nature Medi- cine, 20, 457.
4. Leiter, A., Sablinski, T., Diefenbach, M., Foster, M., Greenberg, A., Holland, J., Oh, W. K. & Galsky, M. D. (2014) Use of crowdsourcing for cancer clinical trial development. Journal of the National Cancer Institute, 106 (10), dju258.
5. Doyle, A. C. (1894) The Memoirs of Sherlock Holmes, p. 22. New York: Harper and Brothers.
6. Siderovski, D. P., Heximer, S. P. & Forsdyke, D. R. (1994) A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA and Cell Biology, 13, 125–147.
7. Tang, M., Wang, G., Lu, P., et al. (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nature Medicine, 9, 1506–1512.
8. Xue, H. Y. & Forsdyke, D. R. (2003) Low complexity segments in Plasmodium falciparum proteins are primarily nucleic acid level adap- tations. Molecular and Biochemical Parasitology, 128, 21–32.
9. Greenhalgh, T., Howick, J. & Maskrey, N. (2014) Evidence based medicine: a movement in crisis? British Medical Journal, 348, g3725.
10. Forsdyke, D. R. (2015) Case report. Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker. BMC Research Notes, 8, 227.
11. Handler, J. (2011) Seasonal variability of blood pressure in California. Journal of Clinical Hypertension, 50, 856–860.
12. Messerli, F. H., Williams, B. & Ritz, E. (2007) Essential hypertension. Lancet, 370, 591–603.
13. Tomlinson, L. A., Abel, G. A., Chaudhry, A. N., Tomson, C. R., Wilkinson, I. B., Roland, M. O. & Payne, R. A. (2013) ACE inhibitor and angiotensin-II receptor antagonist prescribing and hospital admis- sions with acute kidney injury: a longitudinal ecological study. PLoS ONE, 8, e78465.
14. Mancia, G. & Grassi, G. (2014) Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the argument. Hypertension, 63, 29–36.
15. Modesti, P. A., Morabito, M., Massetti, L., Rapi, S., Orlandini, S., Mancia, G., Gensini, G. F. & Parati, G. (2013) Seasonal blood pressure changes. An independent relationship with temperature and daylight hours. Hypertension, 61, 908–914.
1026
16. Cuspidi, C., Ochoa, J. E. & Parati, G. (2012) Seasonal variations in blood pressure: a complex phenomenon. Journal ofHypertension, 30, 1315–1320.
17. Forsdyke, D. R. (2013) Seasonal dosage-dependent hypersensitivity to the angiotensin II receptor blocker, losartan. A case report and review. PeerJ PrePrints, 1, e144v1.
18. Forsdyke, D. R. (2014) Summertime dosage-dependent hypersensi- tivity to an angiotensin II receptor blocker. PeerJ PrePrints,2, e144v2.
19. Forsdyke, D. R. (2000) Tomorrow’s Cures Today? How to Reform the Health Research System. Amsterdam: Harwood Academic.
20. Schatz, G. (2014) The faces of big science. Nature Reviews. Molecular Cell Biology, 15, 423–426.
21. Burchard, E. B. (2014) Missing patients. Nature, 513, 301–302. 22. Cock, A. G. & Forsdyke, D. R. (2008) TreasureYour Exceptions. The Science and Life of William Bateson. NewYork: Springer.
23. Bliss, M. (1988) The Discovery of Insulin. Toronto: McClelland and Stewart.
24. Nissen, T. & Wynn, R. (2014) The clinical case report: a review of its merits and limitations. BMC Research Notes, 7, 264.
25. Burnier, M. & Wuerzner, G. (2011) Pharmacokinetic evaluation of losartan. Expert Opinion on Drug Metabolism & Toxicology, 7, 643– 649.
26. Song, F., Loke, Y. & Hooper, L. (2014) Why are medical and health- related studies not being published? A systematic review of reasons given by investigators. PLoS ONE, 9, e110418